Clinical trial

Effectiveness Study of Scopolamine Combined With Escitalopram in Patients With MDD

NCT03131050

Study summary

ClinicalTrials.gov

Effectiveness Study of Scopolamine Combined With Escitalopram in Patients With MDD

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Mapped RxNorm record Scopolamine Normalized identity: scopolamine View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Escitalopram Normalized identity: escitalopram View linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Saline Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2017-03-15

PhasePHASE4

Conditions

Major Depressive Disorderverified · MONDO: major depressive disorder

Interventions

ScopolamineDRUG · verified · RxNorm: scopolamine

EscitalopramDRUG · verified · RxNorm: escitalopram

SalineDRUG

Sponsors & collaborators

Capital Medical Universitylead sponsor

Mapped research locations

BeijingChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03131050 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.